Clinton Group’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-114,924
Closed -$2.95M 1048
2016
Q4
$2.95M Buy
114,924
+104,276
+979% +$2.74M 0.17% 184
2016
Q3
$291K Buy
+10,648
New +$292K 0.01% 776
2016
Q2
Sell
-36,820
Closed -$870K 1039
2016
Q1
$870K Buy
36,820
+10,260
+39% +$226K 0.05% 458
2015
Q4
$598K Buy
+26,560
New +$606K 0.05% 471

Other funds holding TECH

Clinton Group's TECH Position: Q1 2017 in Review

Clinton Group sold out of Bio-Techne (TECH) in Q1 2017, closing a stake of 114,924 shares — an estimated $2.95M sold.

Clinton Group first reported a position in TECH in Q4 2015 and held it in 4 quarters. The position peaked at $2.95M in Q4 2016. 271 funds tracked by Wall St. Rank hold TECH as of Q1 2017.

  • Clinton Group reported no remaining Bio-Techne position as of Q1 2017 after selling out during the quarter.
  • Clinton Group sold 114,924 Bio-Techne shares in Q1 2017, an estimated $2.95M.
  • Clinton Group first reported a position in Bio-Techne in Q4 2015 and held it in 4 quarters.
  • Clinton Group's Bio-Techne position peaked at $2.95M in Q4 2016.
  • 271 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2017.

Based on Clinton Group's 13F filing for Q1 2017, filed 10 May 2017.